111 INC
YINASDAQTrading Snapshot
- Day Range
- $3.49 β $3.57
- 52-Week Range
- $2.48 β $11.17
- Volume
- $2.81B
- Avg Volume
- $2.04B
- Shares Outstanding
- 8.7M
- Next Earnings
- Nov 11, 2026
Fundamentals Snapshot
- Annual Revenue
- $12.21B
- Last Q Revenue
- $2.30B
- P/E Ratio
- -2.0
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-10.77
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.4%
Why Investors Own YI
- βHigh-growth profile β revenue up +29.8% YoY with expanding US Equity exposure.
- βHealthy economics β 57% gross margin and 19% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
111 INC
YIAbout 111 INC
Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients β comprising pharmacies and wholesalers β with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

111, Inc. Announces Establishment of the Special Committee
111, Inc. Announces Establishment of the Special CommitteePR NewswireSHANGHAI, Sept. 28, 2026SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "

111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
SHANGHAI, Sept. 17, 2026 /PRNewswire/ -- 111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has receive

111, Inc. Announces Second Quarter 2026 Unaudited Financial Results
111, Inc. Announces Second Quarter 2026 Unaudited Financial ResultsPR NewswireSHANGHAI, Sept. 17, 2026Transition from An Asset-Heavy Business Model to An Asset-

Critical Review: 111 (NASDAQ:YI) and SBC Medical Group (NASDAQ:SBC)
SBC Medical Group (NASDAQ: SBC - Get Free Report) and 111 (NASDAQ: YI - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength o